Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion type Assertion NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_head.
- NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_provenance.
- NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion evidence source_evidence_literature NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_provenance.
- NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion SIO_000772 23453647 NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_provenance.
- NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion wasDerivedFrom befree-20140225 NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_provenance.
- NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion wasGeneratedBy ECO_0000203 NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_provenance.